Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Fintel slips after the release of its full-year results is delayed by a week

A look at some of the major movers in London on Monday

Fintel PLC (AIM:FNTL) (Fintel PLC (AIM:FNTL)), the company formerly known SimplyBiz, fell 5.8% to 206p after it said publication of its full-year results would be delayed.

Owing to processing delays in the finalisation of the audited results, the company will now announce its results a week later than originally intended on Tuesday, March 23.

The Fintel board of directors reiterated the financial guidance and outlook statement detailed in the pre-close trading announcement on January 26, including that adjusted earnings per share will be marginally above 11.0p.

1.00pm: Eco (Atlantic) Oil & Gas higher after good news from Guyana

Eco (Atlantic) Oil & Gas Ltd (Eco (Atlantic) Oil & Gas Ltd (AIM:ECO, TSX-V:EOG)) hardened 6.2% to 25.75p after it said the renewal of the Orinduik licence has been signed off by the oil authorities in Guyana.

Colin Kinley, Eco Atlantic’s chief operating officer, said: "We very much appreciate the Government of Guyana's continued support of our exploration and expanding partnership on the Orinduik Block.

“As a group, the JV Partners continue with advanced reprocessing of the geophysical data, in combination with the additional information obtained from regional drilling results, and further evaluation of the Joe and Jethro discoveries.

12.05pm: Applied Graphene to appear at Corrosion 21 Conference & Expo

Applied Graphene Materials PLC (LON:AGM) climbed 6.4% to 41.5p after it revealed its technology is to gain some extra exposure.

The company announced it will be presenting its technology for graphene dispersion in water-based epoxy coatings at the Corrosion 21 Conference & Expo on April 28.

The producer of speciality graphene nanoplatelet dispersions said this technology represents “a major milestone” in the development of performance-enhancing graphene technologies for more sustainable coatings manufacturers.

11.05am: CAP-XX on a charge

CAP-XX Limited (LON:CPX) was on a charge, rising 8.3% to 8.5p after medical company Portal Instruments joined its customer list.

Portal Instruments has selected the CAP-XX (AIM:CPX) GS230F supercap for its advanced needle-free drug delivery platform for self-administering biological medicines.

"The CAP-XX supercapacitor is a key enabler in delivering a fast, concentrated injection that is over within half a second, empowering the patient to more comfortably manage their chronic condition,” said Patrick Anquetil, the chief executive officer of Portal Instruments.

10.10am: Now Provident Financial gets the Amigo Loans treatment

Provident Financial PLC (LON:PFG) shares slumped 26% to 193.2p as it got what might be referred to as Amigo Loand disease.

The company is facing a regulatory inquiry into its Satsuma loans business after the number of complaints from customers surged during lockdown.

UK regulator, the Financial Conduct Authority, is looking into the practices at Provident’s consumer credit division between February 2020 and 2021, the company said in a statement today.

9.15am: SkinBioTherapeutics scrubs up well in its half-year report but Renalytix AI is caught in red-tape

SkinBioTherapeutics PLC (LON:SBTX), up 11% at 54p, scrubbed up well after it released a half-year report.

The company said it expects significant progress in both its food supplement and its cosmetic programmes during 2021.

The life sciences company had a comfortable cash position of £5.5mln as of December 31, after raising £4.45mln in a placing and open offer in October.

Elsewhere in the life sciences sector, the news was not so good for Renalytix AI (Renalytix PLC (AIM:RENX), NASDAQ:RNLX), which saw its shares slide 6.5% to 1,000p after its lead product, KidneyIntelX, was hit by delays in the USA.

The company is waiting on the establishment of the Medicare Coverage of Innovative Technology (MCIT) pathway to provide a coverage roadmap for Medicare beneficiaries nationwide for innovative medical devices and diagnostic tests designated under the Breakthrough Device review programme that also have market authorisation from the US Food and Drug Administration (FDA).

The Centers for Medicare & Medicaid Services (CMS) said it will delay the implementation date of the MCIT rule by 60 days, beginning a 30-day comment period to solicit additional public feedback on the rule.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK